Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells

Shannon D. Langford, Margaret B. Trent, Paul J. Boor

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We have recently reported in vivo disruption of collagen and elastin architecture within blood vessel walls resulting from the selective inhibition of the enzyme semicarbazide-sensitive amine oxidase (SSAO). This study further investigates the effects of SSAO inhibition on extracellular matrix deposition by smooth-muscle cells (SMCs) cultured from neonatal rat hearts. SMCs were characterized, SSAO activity was measured, and soluble and insoluble collagen and elastin in the extracellular matrix (ECM) were quantified. Cultured neonatal rat heart SMC exhibited a monotypic synthetic phenotype that likely represents a myofibroblast. Detectable levels of SSAO activity present throughout 30-d culture peaked at 7-14 d, coinciding with the production of ECM. The addition of enzyme inhibitors and alternate SSAO substrates (benzylamine) produced varied and, in some cases, marked changes in SSAO activity as well as in the composition of mature and soluble matrix components. Similar to our previous in vivo findings, in vitro SSAO inhibition produced aberrations in collagen and elastin deposition by heart SMC. Because changes in SSAO activity are associated with cardiovascular pathologic states, this enzyme may play a protective or modulating role by regulating ECM production during pathologic insult.

Original languageEnglish (US)
Pages (from-to)141-150
Number of pages10
JournalCardiovascular Toxicology
Volume2
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Amine Oxidase (Copper-Containing)
Smooth Muscle Myocytes
Extracellular Matrix
Muscle
Cells
Elastin
Collagen
Cardiac Myocytes
Rats
Myofibroblasts
Blood vessels
Enzyme Inhibitors
Enzymes
Aberrations
Blood Vessels
Phenotype

Keywords

  • Extracellular matrix (ECM)
  • Semicarbazide-sensitive amine oxidase (SSAO)
  • Smooth-muscle cells (SMCs)

ASJC Scopus subject areas

  • Toxicology
  • Cardiology and Cardiovascular Medicine

Cite this

Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells. / Langford, Shannon D.; Trent, Margaret B.; Boor, Paul J.

In: Cardiovascular Toxicology, Vol. 2, No. 2, 2002, p. 141-150.

Research output: Contribution to journalArticle

Langford, Shannon D. ; Trent, Margaret B. ; Boor, Paul J. / Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells. In: Cardiovascular Toxicology. 2002 ; Vol. 2, No. 2. pp. 141-150.
@article{f8135df915274120ae548c3998767bc6,
title = "Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells",
abstract = "We have recently reported in vivo disruption of collagen and elastin architecture within blood vessel walls resulting from the selective inhibition of the enzyme semicarbazide-sensitive amine oxidase (SSAO). This study further investigates the effects of SSAO inhibition on extracellular matrix deposition by smooth-muscle cells (SMCs) cultured from neonatal rat hearts. SMCs were characterized, SSAO activity was measured, and soluble and insoluble collagen and elastin in the extracellular matrix (ECM) were quantified. Cultured neonatal rat heart SMC exhibited a monotypic synthetic phenotype that likely represents a myofibroblast. Detectable levels of SSAO activity present throughout 30-d culture peaked at 7-14 d, coinciding with the production of ECM. The addition of enzyme inhibitors and alternate SSAO substrates (benzylamine) produced varied and, in some cases, marked changes in SSAO activity as well as in the composition of mature and soluble matrix components. Similar to our previous in vivo findings, in vitro SSAO inhibition produced aberrations in collagen and elastin deposition by heart SMC. Because changes in SSAO activity are associated with cardiovascular pathologic states, this enzyme may play a protective or modulating role by regulating ECM production during pathologic insult.",
keywords = "Extracellular matrix (ECM), Semicarbazide-sensitive amine oxidase (SSAO), Smooth-muscle cells (SMCs)",
author = "Langford, {Shannon D.} and Trent, {Margaret B.} and Boor, {Paul J.}",
year = "2002",
doi = "10.1385/CT:2:2:141",
language = "English (US)",
volume = "2",
pages = "141--150",
journal = "Cardiovascular Toxicology",
issn = "1530-7905",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells

AU - Langford, Shannon D.

AU - Trent, Margaret B.

AU - Boor, Paul J.

PY - 2002

Y1 - 2002

N2 - We have recently reported in vivo disruption of collagen and elastin architecture within blood vessel walls resulting from the selective inhibition of the enzyme semicarbazide-sensitive amine oxidase (SSAO). This study further investigates the effects of SSAO inhibition on extracellular matrix deposition by smooth-muscle cells (SMCs) cultured from neonatal rat hearts. SMCs were characterized, SSAO activity was measured, and soluble and insoluble collagen and elastin in the extracellular matrix (ECM) were quantified. Cultured neonatal rat heart SMC exhibited a monotypic synthetic phenotype that likely represents a myofibroblast. Detectable levels of SSAO activity present throughout 30-d culture peaked at 7-14 d, coinciding with the production of ECM. The addition of enzyme inhibitors and alternate SSAO substrates (benzylamine) produced varied and, in some cases, marked changes in SSAO activity as well as in the composition of mature and soluble matrix components. Similar to our previous in vivo findings, in vitro SSAO inhibition produced aberrations in collagen and elastin deposition by heart SMC. Because changes in SSAO activity are associated with cardiovascular pathologic states, this enzyme may play a protective or modulating role by regulating ECM production during pathologic insult.

AB - We have recently reported in vivo disruption of collagen and elastin architecture within blood vessel walls resulting from the selective inhibition of the enzyme semicarbazide-sensitive amine oxidase (SSAO). This study further investigates the effects of SSAO inhibition on extracellular matrix deposition by smooth-muscle cells (SMCs) cultured from neonatal rat hearts. SMCs were characterized, SSAO activity was measured, and soluble and insoluble collagen and elastin in the extracellular matrix (ECM) were quantified. Cultured neonatal rat heart SMC exhibited a monotypic synthetic phenotype that likely represents a myofibroblast. Detectable levels of SSAO activity present throughout 30-d culture peaked at 7-14 d, coinciding with the production of ECM. The addition of enzyme inhibitors and alternate SSAO substrates (benzylamine) produced varied and, in some cases, marked changes in SSAO activity as well as in the composition of mature and soluble matrix components. Similar to our previous in vivo findings, in vitro SSAO inhibition produced aberrations in collagen and elastin deposition by heart SMC. Because changes in SSAO activity are associated with cardiovascular pathologic states, this enzyme may play a protective or modulating role by regulating ECM production during pathologic insult.

KW - Extracellular matrix (ECM)

KW - Semicarbazide-sensitive amine oxidase (SSAO)

KW - Smooth-muscle cells (SMCs)

UR - http://www.scopus.com/inward/record.url?scp=0036368582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036368582&partnerID=8YFLogxK

U2 - 10.1385/CT:2:2:141

DO - 10.1385/CT:2:2:141

M3 - Article

VL - 2

SP - 141

EP - 150

JO - Cardiovascular Toxicology

JF - Cardiovascular Toxicology

SN - 1530-7905

IS - 2

ER -